News

Monitoring CAVI May Improve COPD Management And Help Evaluate Disease Progression: Study
A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...
Medscape4d
COPD Diagnosis Reboot Identifies More At-Risk Individuals
We have developed a new, multidimensional diagnostic schema for COPD that incorporates spirometry, symptoms, and imaging and ...
MedPage Today on MSN6d
Adding CT, Symptoms Improves COPD Diagnosis
The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P ...
Healthline1d
What Is Chronic Obstructive Pulmonary Disease (COPD)?
COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...
Healio1d
Mepolizumab lowers severe exacerbation risk in COPD, type 2 inflammation at 104 weeks
Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...
Medscape4d
Are Your Patients With COPD Inhaling Eucalyptus Oil? Know the Risks
Eucalyptus oil was first used by Aboriginal Australians, who crushed the leaves for their antiseptic properties or steamed ...
The American Journal of Managed Care2d
FDA Approves Mepolizumab as First Once-Monthly Biologic for COPD With Eosinophilic Phenotype
FDA approves mepolizumab (Nucala; GSK) as the first monthly biologic for chronic obstructive pulmonary disease (COPD), significantly reducing exacerbations in patients with an eosinophilic phenotype.
Pulmonology Advisor3d
Women and Lung Disease: Sex-Specific Patterns in COPD, Asthma, and OSA
Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...